Share on StockTwits

Cytomedix (NASDAQ:CMXI) CFO Steven A. Shallcross bought 27,500 shares of Cytomedix stock on the open market in a transaction dated Tuesday, August 26th. The stock was purchased at an average price of $0.38 per share, for a total transaction of $10,450.00. Following the transaction, the chief financial officer now directly owns 79,500 shares of the company’s stock, valued at approximately $30,210. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Cytomedix (NASDAQ:CMXI) opened at 0.369 on Friday. Cytomedix has a 52 week low of $0.33 and a 52 week high of $0.68. The stock’s 50-day moving average is $0.39 and its 200-day moving average is $0.46. The company’s market cap is $45.9 million.

Cytomedix, Inc is a United States-based company that develops biologically active regenerative therapies for wound and tissue repair.

Receive News & Ratings for Cytomedix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytomedix Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.